LAST FEW PLACES FOR THE BOPA NMP MASTERCLASS – FREE TO BOPA MEMBERS

Dear BOPA members,
 
There is less than a month to go for the next BOPA F2F NMP masterclass. Don’t delay and sign up NOW as slots are filling fast. Free for BOPA members!
 
We have an excellent program and have a whole afternoon with “The Method”( https://www.the-method.com/). The  Method offer an interactive exciting session to help you build on your patient consultation skills, this something not offered by any other study day.
 
Please see the link below to register for the “BOPA Masterclass – Non-Medical Prescribing” on Wednesday 4th September 2019.
 
https://www.eventbrite.co.uk/e/bopa-masterclass-non-medical-prescribing-tickets-62562305540
 
Kind Regards
 

Alkesh Patel
BOPA Education and Training Committee Chair
 
British Oncology Pharmacy Association 
www.bopa.org.uk
 

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article